A Real-World Study Assessing the Efficacy and Safety of Switching from Basal-Bolus Insulin Therapy to Once-Daily iGlarLixi in People with Type 2 Diabetes-Soli De-escalation

被引：0
|
作者：
Giorgino, Francesco
Lauand, Felipe, Sr.
Servera, Soraly
Li, Xuan
Taybani, Zoltan
Cheng, Alice Y. Y.
Fonseca, Vivian
Tebaibia, Amar
Anaforoglu, Inan
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1867-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1867-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study
    Mathieu, Chantal
    Weisnagel, S. John
    Stella, Peter
    Bruhwyler, Jacques
    Alexandre, Kathy
    DIABETES THERAPY, 2020, 11 (02) : 495 - 507
  • [2] Switching patients with type 1 and type 2 diabetes on basal-bolus regimen from twice-daily NPH to once-daily insulin detemir leads to improved control and safety
    Aczel, Stefan
    Hansen, Jes B.
    Tsur, Anat
    DIABETES, 2007, 56 : A544 - A544
  • [3] Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
    Tosaka, Yuka
    Kanazawa, Akio
    Ikeda, Fuki
    Iida, Mayu
    Sato, Junko
    Matsumoto, Kazuhisa
    Uchida, Toyoyoshi
    Tamura, Yoshifumi
    Ogihara, Takeshi
    Mita, Tomoya
    Shimizu, Tomoaki
    Goto, Hiromasa
    Ohmura, Chie
    Fujitani, Yoshio
    Watada, Hirotaka
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [4] Initiation of iGlarLixi vs. Basal-Bolus Insulin (BB) in Adults with Type 2 Diabetes (T2D) Advancing from Basal Insulin (BI) Therapy: The SoliComplex Real-World Study
    Pantalone, Kevin M.
    Heller, Caroline
    Lajara, Rosemarie
    Lew, Elisheva
    Li, Xuan
    Dex, Terry A.
    Kilpatrick, Rachel
    DIABETES, 2022, 71
  • [5] A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
    Hideaki Miyoshi
    Mike Baxter
    Takeshi Kimura
    Masakatsu Hattori
    Yukiko Morimoto
    Dion Marinkovich
    Masami Tamiwa
    Takahisa Hirose
    Diabetes Therapy, 2021, 12 : 1341 - 1357
  • [6] A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
    Miyoshi, Hideaki
    Baxter, Mike
    Kimura, Takeshi
    Hattori, Masakatsu
    Morimoto, Yukiko
    Marinkovich, Dion
    Tamiwa, Masami
    Hirose, Takahisa
    DIABETES THERAPY, 2021, 12 (05) : 1341 - 1357
  • [7] Quality of Life in Japanese People with Type 2 Diabetes Switching from Multiple Daily Insulin Injections to Once-Daily iGlarLixi: SIMPLIFY Japan
    Ishii, Hitoshi
    Kamiya, Hideki
    Takahashi, Yoko
    Morimoto, Yukiko
    Yabe, Daisuke
    DIABETES THERAPY, 2024, : 2381 - 2400
  • [8] Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli-SWITCH study
    Haluzik, Martin
    Cypryk, Katarzyna
    Alvarez, Agustina
    Lauand, Felipe
    Genti, Valerie Corp Dit
    Bakiner, Okan Sefa
    Lim, Soo
    DIABETES OBESITY & METABOLISM, 2025,
  • [9] Soli-switch: efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes
    Haluzik, M.
    Lim, S.
    Cypryk, K.
    Alvarez, A.
    Lauand, F.
    Corpdit-Genti, V.
    Bakiner, O. S.
    DIABETOLOGIA, 2024, 67 : S378 - S379
  • [10] Cost-utility analysis of once-weekly insulin icodec and once-daily insulin glargine in patients with type 2 diabetes receiving basal-bolus insulin therapy in China
    Dai, Nan
    Su, Xiaorong
    Wang, Yong
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 377 - 386
12345